MDA 19

Overview

MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 ( CB2 ) , with a K i of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity.

Application

Products | Products > Disease Areas > Pain | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Cannabinoid Receptor

Product Information

• Catalog No.: HY-15451
• CAS No.: 1048973-47-2
• Molecular Formula: C21H23N3O2
• Molecular Weight: 349.43
• Purity: 98.80%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 1.43 mg/mL (4.09 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source